MDMA-Assisted Therapy for PTSD: In conversation with Rick Doblin & Payton Nyquvest
Why is real world evidence important for psychedelic research and how do therapy and psychedelics work together? MAPS founder, Rick…
Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD
Real-world study expands access to MDMA-assisted therapy for patients with PTSD and concurrent disorders and will provide data on a…
Numinus builds on strong MAPS Phase 3 trial results through Compassionate Access Trial of MDMA for PTSD
Yesterday, MAPS announced significant, positive results for their Phase 3 clinical trial of MDMA-assisted therapy for PTSD – a major…
Numinus Congratulates MAPS on Phase 3 Clinical Trial of MDMA for severe PTSD
1 in 11 Canadians will suffer from PTSD in their lifetime. We urgently need new approaches to mental health care…
Numinus and Syreon Provide Psilocybin Compassionate Access Trial Update
Cliquez ici pour la version française Significant progress made as Numinus-sponsored PRIME study on psilocybin-assisted psychotherapy for opioid, stimulant and/or…
Numinus Wellness’s trial for MDMA-assisted therapy is in pre-implementation stage
The study, which is in collaboration with MAPS Public Benefit Corporation (MAPS PBC), subsidiary of the Multidisciplinary Association for Psychedelic…
Numinus announces milestones in compassionate access trial for MDMA-assisted therapy in collaboration with MAPS Public Benefit Corporation
Cliquez ici pour la version française Trial enters pre-implementation stage having met several key milestones towards expanding access to patients…
Numinus and MAPS to Collaborate on MDMA Trial for PTSD
Vancouver-based firm Numinus announced yesterday it will collaborate with an arm of a longstanding non-profit association dedicated to the study…
“Buried by Puppies Licking Your Face” (Canadian Firms Champion MDMA for PTSD)
Numinus Wellness Inc. and Multidisciplinary Association for Psychedelic Studies Public Benefit Corporation (MAPS PBC) have teamed up to petition Health Canada for approval…
Numinus and MAPS Public Benefit Corporation announce collaboration agreement to seek approval of MDMA-assisted psychotherapy for PTSD single-arm, open-label trial
First-of-its-kind trial in Canada will pave the way for expanded MDMA-assisted treatment to support patients with posttraumatic stress disorder VANCOUVER (December…
New Magic Mushroom Clinical Trial to Treat Addiction
Could magic mushrooms treat addiction? Vancouver based company Numinus has announced a new clinical trial of psilocybin-assisted psychotherapy to treat…
Vancouver company announces clinical trial of psilocybin-assisted psychotherapy for substance use disorders
Vancouver-based Numinus Wellness Inc. has announced a 30-person clinical trial to establish the best practices for treating substance use disorders…
Down (the Rabbit Hole) and Out (of Addiction)
Magic Mushrooms, now legal in Oregon. have shown promise in treatment of addiction and depression. The question is — will the…
Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders
Open-label clinical trial will evaluate and refine best practices for the delivery of psilocybin-assisted psychotherapy for participants with tobacco, stimulant,…